# Processa Pharmaceuticals, Inc.: Form 8-K, filed Oct 6, 2020

- Company: [Processa Pharmaceuticals, Inc.](/companies/pcsa.md) (CIK 1533743)
- Form: 8-K
- Filed: 2020-10-06
- Accepted by EDGAR: Oct 6, 2020, 16:05 ET
- Period: 2020-10-01
- Accession: 0001493152-20-019018
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1533743/000149315220019018/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1533743/000149315220019018/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1533743/000149315220019018/form8-k.htm

Filed Oct 6, 2020.
Source: SEC EDGAR, the filing index for accession 0001493152-20-019018. Last ingested by Listed: Nov 14, 2026, 23:30 ET. No prices; not investment advice.
